KIM
AGIO icon

Kestra Investment Management’s Agios Pharmaceuticals AGIO Stock Holding History

Kestra Investment Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-278
Closed -$8.7K – 449
2025
Q2 		$8.7K Buy
278
+139
+100% +$4.21K ﹤0.01% 728
2025
Q1 		$4.07K Buy
+139
New +$4.61K ﹤0.01% 701

Other funds holding AGIO

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Kestra Investment Management's AGIO Position: Q3 2025 in Review

Kestra Investment Management sold out of Agios Pharmaceuticals (AGIO) in Q3 2025, closing a stake of 278 shares — an estimated $8.7K sold.

Kestra Investment Management first reported a position in AGIO in Q1 2025 and held it in 2 quarters. The position peaked at $8.7K in Q2 2025. 220 funds tracked by Wall St. Rank hold AGIO as of Q3 2025.

  • Kestra Investment Management reported no remaining Agios Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Kestra Investment Management sold 278 Agios Pharmaceuticals shares in Q3 2025, an estimated $8.7K.
  • Kestra Investment Management first reported a position in Agios Pharmaceuticals in Q1 2025 and held it in 2 quarters.
  • Kestra Investment Management's Agios Pharmaceuticals position peaked at $8.7K in Q2 2025.
  • 220 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2025.

Based on Kestra Investment Management's 13F filing for Q3 2025, filed 17 Nov 2025.